Ref.: BL-RE-093966Manufacturer ref.: EMTNFSF10X10 10 x 96 tests
€4,815.00 excl. VAT
TRAIL protein is a cytokine belonging to the tumour necrosis factor (TNF) family. Trail protein induces the apoptosis preferably in transformed and tumour cells, but does not appear to kill cells...
Accession number
P50592
Dose range
2.46 to 600 pg/ml
Sensitivity of the dosage
2 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
TRAIL protein is a cytokine belonging to the tumour necrosis factor (TNF) family. Trail protein induces the apoptosis preferably in transformed and tumour cells, but does not appear to kill cells...
TRAIL protein is a cytokine belonging to the tumour necrosis factor (TNF) family. Trail protein induces the apoptosis preferably in the transformed and tumour cells, but does not appear to kill normal cells although it expresses itself at a significant level in most normal tissues. The TRAIL protein binds to several members of the TNF receptor superfamily, including TNFRSF10A / TRAILR1, TNFRSF10B / TRAILR2, TNFRSF10C / TRAILR3, TNFRSF10D / TRAILR4 and possibly also to TNFRSF11B / OPG. The activity of this protein can be modulated by binding to the lure receptors TNFRSF10C / TRAILR3, TNFRSF10D / TRAILR4 and TNFRSF11B / OPG which cannot induce d-apoptosis. The binding of TRAIL protein to its receptors has been shown to trigger activation of the MAPK8/JNK protein, caspase 8 and caspase 3. Trail protein receptors include two receptor-based death domains, Death Receptor 4 (DR4) and DR5, as well as two lure receptors, DcR1 and DcR2, without any intracellular signaling death domain. TRAIL protein is a type II membrane protein and is expressed in a multitude of human tissues. Like TNF and Fas ligand, TRAIL induces l-apoptosis and NF-kB activity in many tissues and cells.
Sensitivity
Sensitivity of dosage: 2 pg/ml.
Measurement range
Dosing range: 2.46 to 600 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.